药品名称NIASPAN TITRATION STARTER PACK
申请号020381产品号005
活性成分NIACIN市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格375MG
治疗等效代码参比药物
批准日期1997/07/28申请机构ABBVIE INC
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
60804282017/05/27U-331PDF格式
历史专利信息
61299302013/09/20U-354PDF格式
64067152013/09/20U-450PDF格式
67466912013/09/20U-586PDF格式
70118482013/09/20U-712PDF格式
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020381051APLabel2015/04/27下载
020381051APLetter2015/04/28下载
020381048APLetter2013/02/25下载
020381048APLabel2013/02/26下载
020381043APLetter2010/11/12下载
020381043APLabel2010/11/12下载
020381042APLetter2010/03/03下载
020381042APLabel2010/03/03下载
020381041APLetter2009/11/12下载
020381041APLabel2009/09/21下载
020381039APLetter2009/11/12下载
020381039APLabel2009/09/21下载
020381038APLetter2009/04/01下载
020381034APLabel2007/12/27下载
020381034APLetter2008/01/09下载
020381032APLetter2008/05/30下载
020381027APLetter2007/04/09下载
020381025APLabel2006/04/12下载
020381025APLetter2006/04/12下载
020381023APLetter2005/09/15下载
020381023APLabel2005/09/15下载
020381020APLetter2005/06/10下载
020381020APLabel2005/06/10下载
020381013APLabel2003/03/05下载
020381013APLetter2004/06/10下载
020381007APLetter1999/09/13下载
020381006APLetter1999/10/28下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020381052AP2015/10/28Manufacturing Change or Addition
020381051AP2015/04/27Labeling Revision
020381050AP2015/05/27Manufacturing Change or Addition
020381049AP2013/06/18Manufacturing Change or Addition
020381048AP2013/02/21Labeling Revision
020381043AP2010/11/09Labeling Revision
020381042AP2010/02/24Labeling Revision
020381041AP2009/09/16Labeling Revision
020381039AP2009/09/16Labeling Revision
020381038AP2009/03/26Labeling Revision
020381034AP2007/12/18Labeling Revision
020381032AP2008/05/29Labeling Revision
020381027AP2007/04/04Control Supplement
020381025AP2006/04/11Labeling Revision
020381023AP2005/09/09Formulation Revision
020381020AP2005/06/08Labeling Revision
020381014AP2002/09/05Control Supplement
020381013AP2003/01/31New or Modified Indication
020381012AP2000/11/24Manufacturing Change or Addition
020381011AP2000/08/02Control Supplement
020381010AP2000/08/02Control Supplement
020381009AP2000/06/09Control Supplement
020381008AP2000/05/08Manufacturing Change or Addition
020381007AP1999/09/13New Dosage Regimen
020381006AP1999/10/28New or Modified Indication
020381004AP1998/08/24Manufacturing Change or Addition
020381003AP1998/05/12Manufacturing Change or Addition
020381002AP1998/03/02Control Supplement
020381001AP1998/03/23Manufacturing Change or Addition
020381000AP1997/07/28Approval